Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Julia Reichelt

Newcastle AuthorsTitleYearFull text
Oliver March
Dr Julia Reichelt
Gene editing for skin diseases: Designer nucleases as tools for gene therapy of skin fragility disorders2018
Oliver March
Dr Magomet Aushev
Dr Julia Reichelt
Developing an optimised TALEN-mediated ex vivo gene therapy for epidermolytic ichthyosis2016
Oliver March
Dr Magomet Aushev
Dr Julia Reichelt
Gene editing of keratinocyte stem cells for a novel ex vivo epidermolytic ichthyosis therapy2016
Dr Julia Reichelt
Keratins K2 and K10 are essential for the epidermal integrity of plantar skin2016
Dr Julia Reichelt
Oliver March
Dr Magomet Aushev
Optimised TALEN-mediated Gene Editing of Keratinocyte Stem Cells for a Novel Ex Vivo Epidermolytic Ichthyosis Therapy2016
Dr Magomet Aushev
Dr Julia Reichelt
Optimised TALEN-mediated gene editing of keratinocyte stem cells for a novel ex vivo epidermolytic ichthyosis therapy2016
Dr Magomet Aushev
Dr Julia Reichelt
TALEN-mediated elimination of mutant keratin 14 as a gene therapy for epidermolysis bullosa simplex2016
Dr Magomet Aushev
Dr Julia Reichelt
TALEN-mediated elimination of mutant keratin 14 as a gene therapy for epidermolysis bullosa simplex2016
Oliver March
Dr Magomet Aushev
Dr Julia Reichelt
A TALEN-mediated gene therapy for epidermolytic ichthyosis2015
Oliver March
Dr Magomet Aushev
Dr Julia Reichelt
A TALEN-mediated gene therapy for epidermolytic ichthyosis2015
Dr Julia Reichelt
Deletion of suprabasal keratins K2 and K10 causes upregulation of K1 and K16 in plantar skin2015
Dr Magomet Aushev
Dr Julia Reichelt
Functional inactivation of mutant keratin 14 as a gene therapy for epidermolysis bullosa simplex using programmable nucleases2015
Dr Magomet Aushev
Dr Julia Reichelt
TALEN-mediated elimination of mutant keratin 14 as a gene therapy for epidermolysis bullosa simplex2015
Dr Julia Reichelt
Targeted deletion of suprabasal keratins K2 and K10 causes upregulation of K1 and K162015
Dr Julia Reichelt
Targeted deletion of suprabasal keratins K2 and K10 causes upregulation of K1 and K162015
1234